Ameriprise’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.61M | Buy |
372,467
+46,770
| +14% | +$955K | ﹤0.01% | 2018 |
|
|
2025
Q1 | $6.52M | Buy |
325,697
+9,661
| +3% | +$193K | ﹤0.01% | 2098 |
|
|
2024
Q4 | $8.42M | Sell |
316,036
-33,193
| -10% | -$885K | ﹤0.01% | 1928 |
|
|
2024
Q3 | $9.96M | Buy |
349,229
+55,207
| +19% | +$1.57M | ﹤0.01% | 1805 |
|
|
2024
Q2 | $6.4M | Sell |
294,022
-1,305
| -0.4% | -$28.4K | ﹤0.01% | 2113 |
|
|
2024
Q1 | $6.54M | Buy |
295,327
+15,600
| +6% | +$346K | ﹤0.01% | 2156 |
|
|
2023
Q4 | $6.04M | Buy |
279,727
+13,727
| +5% | +$296K | ﹤0.01% | 2209 |
|
|
2023
Q3 | $4.49M | Sell |
266,000
-51,954
| -16% | -$878K | ﹤0.01% | 2359 |
|
|
2023
Q2 | $4.36M | Buy |
317,954
+203,045
| +177% | +$2.79M | ﹤0.01% | 2446 |
|
|
2023
Q1 | $2.61M | Buy |
114,909
+3,670
| +3% | +$83.4K | ﹤0.01% | 2708 |
|
|
2022
Q4 | $2.62M | Sell |
111,239
-21,281
| -16% | -$501K | ﹤0.01% | 2691 |
|
|
2022
Q3 | $3.46M | Sell |
132,520
-27,634
| -17% | -$721K | ﹤0.01% | 2486 |
|
|
2022
Q2 | $3.52M | Buy |
160,154
+36,586
| +30% | +$803K | ﹤0.01% | 2521 |
|
|
2022
Q1 | $5.55M | Buy |
123,568
+14,247
| +13% | +$639K | ﹤0.01% | 2355 |
|
|
2021
Q4 | $4.69M | Buy |
109,321
+17,034
| +18% | +$730K | ﹤0.01% | 2505 |
|
|
2021
Q3 | $6.14M | Sell |
92,287
-1,005
| -1% | -$66.8K | ﹤0.01% | 2248 |
|
|
2021
Q2 | $6.84M | Sell |
93,292
-15,760
| -14% | -$1.16M | ﹤0.01% | 2227 |
|
|
2021
Q1 | $7.47M | Sell |
109,052
-24,950
| -19% | -$1.71M | ﹤0.01% | 2106 |
|
|
2020
Q4 | $9M | Sell |
134,002
-11,914
| -8% | -$800K | ﹤0.01% | 1829 |
|
|
2020
Q3 | $7.51M | Buy |
145,916
+46,923
| +47% | +$2.41M | ﹤0.01% | 1776 |
|
|
2020
Q2 | $3.73M | Buy |
98,993
+60,993
| +161% | +$2.3M | ﹤0.01% | 2267 |
|
|
2020
Q1 | $1.13M | Buy |
+38,000
| New | +$1.13M | ﹤0.01% | 2764 |
|